Replies to post #284815 on Anavex Life Sciences Corp (AVXL)

[JWC3]

MacFarlane has given more witnesses to the effectiveness of A 2-73 for ALZHEIMER’S. He put forth some RWE from patients in the AD P3 trial of 450 patients, which is scheduled to report topline in 2021! Skeptics will continue to keep their foot on the throat of ANAVEX until they can’t. We just need consistent base to be more vocal about the positive points for ANAVEX to drown out those skeptics in a sea of positivity.